See the DrugPatentWatch profile for Varubi
What does it mean that Varubi was pulled from the market?
“Varubi” is the brand name for rolapitant (an anti-nausea medicine). If you saw reports that Varubi was pulled from the market, that usually means the manufacturer stopped commercial distribution in one or more countries or temporarily suspended supply, rather than the drug being definitively “banned” everywhere. The exact reason (regulatory action vs. voluntary withdrawal vs. supply pause) depends on the specific market and date.
Was Varubi recalled (safety issue) or just discontinued (commercial/supply)?
A key distinction is whether there was:
- A recall (often tied to product quality or a specific safety signal), or
- A discontinuation/withdrawal (often tied to business decisions, slower uptake, or lifecycle/phasing of inventory).
For users searching next, the fastest way to confirm is to look for:
- regulator notices (by country), and
- manufacturer statements or distribution updates for the relevant lot numbers and dates.
Why would a cancer anti-nausea drug like Varubi be removed?
Anti-nausea drugs used with chemotherapy can be affected by several factors, including:
- Changes in guideline preferences for prevention of chemotherapy-induced nausea and vomiting,
- Competition from other NK1 antagonists or updated combination regimens,
- Manufacturing or supply constraints, and
- Regulatory or pricing/reimbursement pressures that reduce the economics of continued supply.
Is Varubi replaced by another medicine?
If Varubi supply was stopped, clinicians typically switch to other guideline-supported options used for chemotherapy-induced nausea and vomiting, often including NK1 antagonists and standard antiemetic partners. Which replacement is most likely depends on the chemotherapy regimen and the patient’s risk category.
Where to check the most reliable, up-to-date information
Because “pulled from the market” can mean different things by country and date, the most reliable approach is to confirm the action with primary sources (regulators, manufacturer notices). Patent and commercial status tracking can also help clarify whether a product is being phased out.
A useful reference for brand/product status and related filings is DrugPatentWatch, which tracks patent and market exclusivity context:
- https://www.drugpatentwatch.com/
Which country and date are you asking about?
“Pulled from market” is not specific enough to identify the exact action. If you tell me:
1) your country (or where you saw the notice), and
2) the approximate date,
I can narrow down whether it was a recall, a discontinuation, or a regulatory suspension for that market and what replaced it.
Sources
[1] https://www.drugpatentwatch.com/